Combatting Mycophenolate Risks in the Military Community: An Impactful Microlearning Approach to Strengthen the Delivery of REMS Compliant Care

THIS ACTIVITY IS ONLY BEING MAINTAINED FOR ACCREDITATION REVIEW

VIDEO Only -

This Mycophenolate REMS-compliant activity was designed to educate healthcare providers about the management of female patients of reproductive potential who are prescribed mycophenolate — particularly those professionals who care/may care for active military members and Veterans. Female members of the Military Community are at a high risk for autoimmune disease and are likely to be prescribed mycophenolate during their child-bearing years. Studies have shown that women in the Military Community often do not receive risk-lowering care when prescribed teratogenic medications like mycophenolate. This microlearning activity provides comprehensive education on reducing the risk of embryofetal toxicity associated with the use of mycophenolate during pregnancy in eight 15-minute episodes. Each episode will be presented as a video, audio-only file, or monograph to allow the learner to create an optional learning experience that best aligns with their learning style.

Target Audience

The intended audience includes physicians, nurse practitioners, nurses, physician assistants, pharmacists and other providers involved in the management of female patients of reproductive potential who are prescribed mycophenolate.

Learning Objectives

After completing the educational activity, participants should be able to:

  • Identify the increased risks of first trimester pregnancy loss and congenital malformations associated with mycophenolate. 

  • Develop strategies for educating females of reproductive potential about the risks of exposure to mycophenolate during pregnancy.

  • Plan the management of mycophenolate in females of reproductive potential.

  • Summarize provider responsibilities for reporting pregnancies to the Mycophenolate Pregnancy Registry and the importance of patient participation in the Mycophenolate Pregnancy Registry.

Commercial Support
This activity is supported by an independent educational grant from the Mycophenolate REMS Group. This activity is intended to be fully compliant with the Mycophenolate REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Course summary

Available credit: 
  • 2.00 AANP Contact Hours

    Nurse Practitioners
    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and .  AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.00 contact hour(s) (which includes 2.00 hour(s) of pharmacology).

  • 2.00 AAPA Category 1 CME

    Physician Associates
    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 2.00 ACPE Pharmacist

    Pharmacists
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2.00 contact hours.

  • 2.00 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC Contact Hours

    Nurses
    Credit being awarded: 2.00 ANCC contact hours

  • 2.00 Attendance

    Credits: 2.00

Course opens: 
10/27/2025
Course expires: 
10/27/2026
Cost:
$0.00
Rating: 
0

Faculty & Planner

Alicia Y. Christy MD, MHSCR (Chair)
Colonel (retired)
Dr Christy has nothing to disclose.

Evelyn Lewis, MD, MA, FAAFP, DABDA 
President and Chair, Veterans Health and Wellness Foundation
Adjunct Associate Professor, Rutgers RWJMS
Newnan, GA
Dr Lewis has nothing to disclose.

Jessica Lee Lin, MPAP
Physician Assistant
University of California, San Diego  
San Diego, CA
Ms. Lee has nothing to disclose.

Monica L Reynolds, MD, MSCR
Associate Professor
UNC Nephrology and Hypertension
Dr Reynolds has the following financial relationship: Speaker - Travere Therapeutics

Stephanie Widmer, DO 
Medical Toxicologist & Attending Physician
St John's Riverside Hospital, Yonkers, NY
Dr Widmer has nothing to disclose.

Dorothy Duffy, RPh
Independent Pharmacist
Immunization Director, Medication Therapy Management Provider
Colonial Pharmacy
Clifton, NJ
Ms Duffy has nothing to disclose.

Hailey Ehmke - Nurse Student
Ms. Ehmke has nothing to disclose

Calla Ehmke - Patient
Ms. Ehmke has nothing to disclose

Alexandra Poch - Patient
Ms. Poch has nothing to disclose

Independent Reviewer
Daniel Sessions, MD
Chief, Division of Medical Toxicology
Ochsner Health Foundation
Senior Lecturer in Emergency Medicine, University of Queensland
New Orleans, LA
Dr Sessions has nothing to disclose

Planners and Reviewers
Dorothy Caputo, MA, BSN, RN, AKH President (Planner), has nothing to disclose.
Deborah C. Clark, PhD, AKH Vice President (Planner), has nothing to disclose.
Michele Bielarski, RN (Reviewer) has nothing to disclose.
Bernadette Makar, MSN, APRN-BC, NP-C (Reviewer) has nothing to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare, Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 2 Interprofessional Continuing Education (IPCE) credit for learning and change.


Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2 contact hours.

Nursing
Credit being awarded: 2 ANCC contact hours

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 AAPA Category 1 CME credits. Approval is valid until 10/27/2026. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare, Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2 contact hour(s) (which includes 2 hour(s) of pharmacology).

Available Credit

  • 2.00 AANP Contact Hours

    Nurse Practitioners
    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and .  AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.00 contact hour(s) (which includes 2.00 hour(s) of pharmacology).

  • 2.00 AAPA Category 1 CME

    Physician Associates
    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 2.00 ACPE Pharmacist

    Pharmacists
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2.00 contact hours.

  • 2.00 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC Contact Hours

    Nurses
    Credit being awarded: 2.00 ANCC contact hours

  • 2.00 Attendance

    Credits: 2.00

Price

Cost:
$0.00
Please login or register to take this course.

Navigating the course:

  1. To begin, select the first item under Course Progress to the left, then click Start.

  2. Click Next to continue through the activity.

  3. You can save and resume your progress at any time.

Criteria for Success:

To obtain a certificate of completion, a score of 70% or better on each of the post-tests is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-tests and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit.

Your online certificate will be saved on AKHCME within My Account > My Activities, which you can access at any time.

If you have questions about this activity, please contact AKH Inc. at [email protected].